Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Pittsburgh, Pennsylvania
- Most recent report
- 8-K, filed Jul 15, 2026
- Incorporated
- Delaware
- Filings on record
- 225 filings
- On EDGAR
- CIK 1347242
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 8 of 12
News 8 of 50
- 8-K Current report on a material event Jul 15, 2026
- 8-K Current report on a material event Mar 31, 2026
- 8-K Leadership change Feb 4, 2026
- 8-K Leadership change Oct 21, 2025
- 8-K Leadership change Oct 9, 2025
- 8-K Other events Sep 18, 2025
- 8-K Other events Jun 25, 2025
- 8-K Current report on a material event Jun 20, 2025
Prospectuses and Registrations 8 of 26
- 25-NSE Notice that a security was delisted Oct 6, 2025
- 424B5 Prospectus supplement for an offering Apr 4, 2025
- 424B3 Prospectus supplement for an offering Apr 4, 2025
- S-3 Shelf registration statement Mar 28, 2025
- 424B3 Prospectus supplement for an offering Jan 16, 2025
- S-3 Shelf registration statement Jan 7, 2025
- 424B5 Prospectus supplement for an offering Aug 1, 2024
- S-8 Registration statement for an employee plan Mar 15, 2024
Proxies 8 of 9
- PRE 14A Preliminary proxy statement Jun 10, 2025
- DEFA14A Extra proxy material Dec 20, 2024
- DEFA14A Extra proxy material Dec 6, 2024
- DEF 14A Proxy statement for a shareholder vote Nov 12, 2024
- PRE 14A Preliminary proxy statement Nov 1, 2024
- DEF 14A Proxy statement for a shareholder vote Aug 12, 2024
- PRE 14A Preliminary proxy statement Jul 30, 2024
- DEFA14A Extra proxy material Oct 11, 2023
Ownership 8 of 74
- SCHEDULE 13G/A Large holder reported a passive stake, amended May 1, 2025
- SCHEDULE 13D/A Large holder reported an active stake, amended Apr 9, 2025
- SCHEDULE 13D/A Large holder reported an active stake, amended Apr 9, 2025
- SCHEDULE 13D/A Large holder reported an active stake, amended Apr 7, 2025
- 4 Insider reported a trade Apr 7, 2025
- SCHEDULE 13D/A Large holder reported an active stake, amended Mar 19, 2025
- SCHEDULE 13D/A Large holder reported an active stake, amended Mar 17, 2025
- 4 Insider reported a trade Mar 17, 2025
Other 8 of 54
- EFFECT Notice that a registration became effective Apr 3, 2025
- CORRESP Reply to SEC staff Apr 1, 2025
- D Apr 1, 2025
- UPLOAD Comment letter from SEC staff Mar 31, 2025
- EFFECT Notice that a registration became effective Jan 15, 2025
- CORRESP Reply to SEC staff Jan 13, 2025
- UPLOAD Comment letter from SEC staff Jan 13, 2025
- D Jan 7, 2025
Everything here comes from Lipella Pharmaceuticals Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.